|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.880 CAD | +1.62% |
|
+1.62% | +106.59% |
| 15/19/15 | Emblem Corp. Reports Earnings Results for the Full Year Ended December 31, 2018 | CI |
| 19/19/19 | Emblem Corp.(TSXV:EMC) dropped from S&P/TSX Venture Composite Index | CI |
| Market Cap | 25Cr 22Cr 20Cr 19Cr 35Cr 2.39TCr 36Cr 240.86Cr 94Cr 1.18TCr 93Cr 91Cr 4.07TCr | P/E 2017 |
-16.3x | P/E 2018 | -4.48x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 19Cr 18Cr 16Cr 31Cr 2.11TCr 31Cr 212.69Cr 83Cr 1.04TCr 82Cr 81Cr 3.59TCr | EV / Sales 2017 |
7,23,52,077x | EV / Sales 2018 | 1,09,15,686x |
| Free-Float |
98.36% | Yield 2017 * |
-
| Yield 2018 | - |
| 1 day | +1.62% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tricia Symmes
CEO | Chief Executive Officer | - | - |
Nick Dean
CEO | Chief Executive Officer | - | 01/12/2017 |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John H. Stewart
BRD | Director/Board Member | - | - |
Jeffrey Fineberg
BRD | Director/Board Member | - | - |
Terry Johnson
BRD | Director/Board Member | - | 06/12/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.62% | +1.62% | - | - | 0 | |
| -1.35% | -0.82% | -9.78% | -5.27% | 1.34TCr | |
| -2.94% | -3.76% | -30.91% | -51.86% | 507.59Cr | |
| -0.78% | +1.50% | -0.20% | +1.56% | 479.57Cr | |
| -3.19% | -0.61% | +2.12% | -33.68% | 404.66Cr | |
| -2.43% | -3.43% | +1.38% | -9.56% | 363.24Cr | |
| -1.33% | +1.56% | -2.06% | -4.58% | 362.89Cr | |
| -1.19% | +2.47% | -2.66% | +10.52% | 347.73Cr | |
| -2.28% | -0.77% | -14.46% | -24.09% | 240.47Cr | |
| -3.10% | -2.19% | -5.23% | +40.27% | 182.23Cr | |
| Average | -1.70% | -2.62% | -6.87% | -8.52% | 423.23Cr | |
| Weighted average by Cap. | -1.86% | -2.83% | -7.96% | -10.92% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 2.69 2.37 2.2 2.02 3.79 259.44 3.85 26.13 10.21 127.55 10.11 9.9 441 | 8.22 7.22 6.72 6.16 11.58 791.88 11.76 79.76 31.16 389.32 30.87 30.2 1.35T |
| Net income | -1.21Cr -1.06Cr -98.84L -90.7L -1.7Cr -116.53Cr -1.73Cr -12Cr -4.59Cr -57Cr -4.54Cr -4.44Cr -198.09Cr | -2.43Cr -2.13Cr -1.98Cr -1.82Cr -3.42Cr -233.62Cr -3.47Cr -24Cr -9.19Cr -114.85Cr -9.11Cr -8.91Cr -397.11Cr |
| Net Debt | -2.15Cr -1.89Cr -1.76Cr -1.61Cr -3.03Cr -207.16Cr -3.08Cr -21Cr -8.15Cr -101.85Cr -8.08Cr -7.9Cr -352.14Cr | -2.91Cr -2.55Cr -2.37Cr -2.18Cr -4.09Cr -279.78Cr -4.15Cr -28Cr -11Cr -137.55Cr -11Cr -11Cr -475.59Cr |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- EMC Stock
Select your edition
All financial news and data tailored to specific country editions
